🇮🇹 UMECLIDINIUM BROMIDE in Italy

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in Italy?

Marketing authorisation holder not available in our data.